Krishna M. Ella

2.9k total citations
31 papers, 1.0k citations indexed

About

Krishna M. Ella is a scholar working on Molecular Biology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Krishna M. Ella has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Infectious Diseases and 5 papers in Cell Biology. Recurrent topics in Krishna M. Ella's work include Protein Kinase Regulation and GTPase Signaling (10 papers), Viral gastroenteritis research and epidemiology (4 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Krishna M. Ella is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (10 papers), Viral gastroenteritis research and epidemiology (4 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Krishna M. Ella collaborates with scholars based in United States and India. Krishna M. Ella's co-authors include Kathryn E. Meier, Viswanathan Mohan, Joseph W. Dolan, Qi Chen, Stewart M. Knoepp, Myron M. Levine, Marcela F. Pasetti, Vineeth Varanasi, G. Patrick Meier and Eric C. Spivey and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Clinical Infectious Diseases.

In The Last Decade

Krishna M. Ella

30 papers receiving 980 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krishna M. Ella United States 21 469 375 169 164 145 31 1.0k
Gauranga Mukhopadhyay India 22 460 1.0× 267 0.7× 74 0.4× 49 0.3× 59 0.4× 41 1.1k
Masataka Oda Japan 24 426 0.9× 577 1.5× 228 1.3× 67 0.4× 35 0.2× 41 1.2k
Oanh Pham United States 13 249 0.5× 166 0.4× 61 0.4× 142 0.9× 122 0.8× 19 794
Takahiro Nomura Japan 20 602 1.3× 174 0.5× 76 0.4× 61 0.4× 72 0.5× 74 1.2k
Takashi Umeyama Japan 25 683 1.5× 597 1.6× 61 0.4× 196 1.2× 61 0.4× 68 1.4k
Christina Scherer United States 17 608 1.3× 111 0.3× 281 1.7× 22 0.1× 91 0.6× 26 1.3k
Samira Dahesh United States 18 409 0.9× 189 0.5× 352 2.1× 31 0.2× 47 0.3× 38 1.0k
Brooke A. Napier United States 17 650 1.4× 135 0.4× 53 0.3× 63 0.4× 48 0.3× 23 1.2k
Helena Thomaides‐Brears United Kingdom 18 607 1.3× 296 0.8× 33 0.2× 37 0.2× 178 1.2× 35 1.4k
Jane M. Knisely United States 9 342 0.7× 128 0.3× 39 0.2× 170 1.0× 42 0.3× 12 920

Countries citing papers authored by Krishna M. Ella

Since Specialization
Citations

This map shows the geographic impact of Krishna M. Ella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna M. Ella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna M. Ella more than expected).

Fields of papers citing papers by Krishna M. Ella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna M. Ella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna M. Ella. The network helps show where Krishna M. Ella may publish in the future.

Co-authorship network of co-authors of Krishna M. Ella

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna M. Ella. A scholar is included among the top collaborators of Krishna M. Ella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna M. Ella. Krishna M. Ella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yuhuan, et al.. (2024). Characterization of Lysophospholipase D Activity in Mammalian Cell Membranes. Cells. 13(6). 520–520. 2 indexed citations
2.
Vadrevu, Krishna Mohan, Brunda Ganneru, Siddharth Reddy, et al.. (2022). Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants. Scientific Reports. 12(1). 12038–12038. 22 indexed citations
3.
Ella, Krishna M. & Viswanathan Mohan. (2020). Coronavirus Vaccines: Light at the End of the Tunnel. Indian Pediatrics. 1 indexed citations
4.
5.
Ella, Krishna M., et al.. (2017). Protective efficacy of Zika vaccine in AG129 mouse model. Scientific Reports. 7(1). 46375–46375. 81 indexed citations
6.
Mitra, Monjori, Gadey Sampath, Balaji Krishnamurthy, et al.. (2015). A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains. The Journal of Infectious Diseases. 212(5). 715–725. 50 indexed citations
8.
Hegde, Nagendra R., Deepak Kumar, P P Rao, et al.. (2014). Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India. Vaccine. 32(29). 3636–3643. 8 indexed citations
9.
Bhan, M. K., Roger I. Glass, Krishna M. Ella, et al.. (2014). Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development. The Lancet. 383(9935). 2180–2183. 16 indexed citations
10.
Ella, Krishna M., et al.. (2012). Genetic diversity of chikungunya virus, India 2006–2010: Evolutionary dynamics and serotype analyses. Journal of Medical Virology. 84(3). 462–470. 41 indexed citations
11.
Khajuria, Anamika, Amit Gupta, Pankaj Suden, et al.. (2007). Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrata. Phytotherapy Research. 22(3). 340–348. 34 indexed citations
12.
Khajuria, Anamika, Amit Gupta, Fayaz Malik, et al.. (2007). A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine. 25(23). 4586–4594. 42 indexed citations
13.
Khajuria, Anamika, Amit Gupta, Surjeet Singh, et al.. (2006). RLJ-NE-299A: A new plant based vaccine adjuvant. Vaccine. 25(14). 2706–2715. 28 indexed citations
14.
Meier, Kathryn E., et al.. (1999). Expression of phospholipase D isoforms in mammalian cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1439(2). 199–213. 74 indexed citations
15.
Chen, Qi, et al.. (1998). Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells. Journal of Cellular Physiology. 174(2). 261–272. 60 indexed citations
16.
Meier, Kathryn E., et al.. (1998). Effects of Propranolol on Phosphatidate Phosphohydrolase and Mitogen-Activated Protein Kinase Activities in A7r5 Vascular Smooth Muscle Cells. Cellular Signalling. 10(6). 415–426. 28 indexed citations
17.
Ella, Krishna M., et al.. (1997). Utilization of alcohols by plant and mammalian phospholipase D. IUBMB Life. 41(4). 715–724. 35 indexed citations
18.
Ella, Krishna M., et al.. (1996). Effects of Ara‐C on neutral sphingomyelinase and mitogen‐and stress‐activated protein kinases in T‐lymphocyte cell lines. IUBMB Life. 40(4). 709–719. 20 indexed citations
19.
Knoepp, Stewart M., et al.. (1996). Synergistic Effects of Insulin and Phorbol Ester on Mitogen-activated Protein Kinase in Rat-1 HIR Cells. Journal of Biological Chemistry. 271(3). 1678–1686. 18 indexed citations
20.
Ella, Krishna M., et al.. (1996). Effects of phorbol ester on phospholipase D and mitogen-activated protein kinase activities in T-lymphocyte cell lines. Immunology Letters. 53(2-3). 69–76. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026